LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 1 of total 1

Search options

Article: Impaired basolateral sorting of pro-EGF causes isolated recessive renal hypomagnesemia.

Groenestege, Wouter M Tiel / Thébault, Stéphanie / van der Wijst, Jenny / van den Berg, Dennis / Janssen, Rob / Tejpar, Sabine / van den Heuvel, Lambertus P / van Cutsem, Eric / Hoenderop, Joost G / Knoers, Nine V / Bindels, René J

The Journal of clinical investigation

2007  Volume 117, Issue 8, Page(s) 2260–2267

Abstract: ... The mutation leads to impaired basolateral sorting of pro-EGF. As a consequence, the renal EGFR is inadequately ... of a mutation in the EGF gene in isolated autosomal recessive renal hypomagnesemia, we have, for what we believe ... Primary hypomagnesemia constitutes a rare heterogeneous group of disorders characterized by renal ...

Abstract Primary hypomagnesemia constitutes a rare heterogeneous group of disorders characterized by renal or intestinal magnesium (Mg(2+)) wasting resulting in generally shared symptoms of Mg(2+) depletion, such as tetany and generalized convulsions, and often including associated disturbances in calcium excretion. However, most of the genes involved in the physiology of Mg(2+) handling are unknown. Through the discovery of a mutation in the EGF gene in isolated autosomal recessive renal hypomagnesemia, we have, for what we believe is the first time, identified a magnesiotropic hormone crucial for total body Mg(2+) balance. The mutation leads to impaired basolateral sorting of pro-EGF. As a consequence, the renal EGFR is inadequately stimulated, resulting in insufficient activation of the epithelial Mg(2+) channel TRPM6 (transient receptor potential cation channel, subfamily M, member 6) and thereby Mg(2+) loss. Furthermore, we show that colorectal cancer patients treated with cetuximab, an antagonist of the EGFR, develop hypomagnesemia, emphasizing the significance of EGF in maintaining Mg(2+) balance.
MeSH term(s) Animals ; Antibodies, Monoclonal/adverse effects ; Antibodies, Monoclonal/therapeutic use ; Antibodies, Monoclonal, Humanized ; Antineoplastic Agents/adverse effects ; Antineoplastic Agents/therapeutic use ; Cetuximab ; Colorectal Neoplasms/complications ; Colorectal Neoplasms/drug therapy ; Epidermal Growth Factor/genetics ; Epidermal Growth Factor/metabolism ; Female ; Humans ; Kidney/metabolism ; Magnesium/metabolism ; Male ; Mutation ; Pedigree ; Protein Precursors/genetics ; Protein Precursors/metabolism ; Protein Processing, Post-Translational/drug effects ; Protein Processing, Post-Translational/genetics ; Receptor, Epidermal Growth Factor/genetics ; Receptor, Epidermal Growth Factor/metabolism ; Renal Tubular Transport, Inborn Errors/chemically induced ; Renal Tubular Transport, Inborn Errors/genetics ; Renal Tubular Transport, Inborn Errors/metabolism ; TRPM Cation Channels/biosynthesis ; TRPM Cation Channels/genetics ; Tetany/chemically induced ; Tetany/genetics ; Tetany/metabolism
Chemical Substances Antibodies, Monoclonal ; Antibodies, Monoclonal, Humanized ; Antineoplastic Agents ; Protein Precursors ; TRPM Cation Channels ; TRPM6 protein, human ; epidermal growth factor precursor ; Epidermal Growth Factor (62229-50-9) ; EGFR protein, human (EC 2.7.10.1) ; Receptor, Epidermal Growth Factor (EC 2.7.10.1) ; Magnesium (I38ZP9992A) ; Cetuximab (PQX0D8J21J)
Language English
Publishing date 2007-08
Publishing country United States
Document type Clinical Trial ; Journal Article ; Research Support, Non-U.S. Gov't
ZDB-ID 3067-3
ISSN 1558-8238 ; 0021-9738
ISSN (online) 1558-8238
ISSN 0021-9738
DOI 10.1172/JCI31680
Shelf mark
Ua VI Zs.184: Show issues Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular
ab Jg. 2022: Lesesaal (EG)
Database MEDical Literature Analysis and Retrieval System OnLINE

More links

Kategorien

To top